Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Bakersfield
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Bakersfield, CA

Studies commonly pay $75 to $4,500 per completed study

65 clinical trials are currently recruiting participants within 30 miles of Bakersfield. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

65studies recruiting
7+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Bakersfield right now

Top 25 of 65 recruiting studies, sorted by proximity — each links to its official registry page

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD Phase 2 Interventional 15 participants sought
Adverum site 109 — Bakersfield, California (1.7 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07630649)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06992427)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Pruritus Phase 3 Interventional 284 participants sought
Kern Allergy and Medical Research- Site Number : 8400016 — Bakersfield, California (1.7 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT05263206)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

COVID-19 SARS-CoV-2 Infection Phase 3 Interventional 2,330 participants sought
National Institute of Clinical Research - Bakersfield — Bakersfield, California (1.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06679140)

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Retinitis Pigmentosa Phase 2 Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: jCyte, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06912633)

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

Stargardt Disease Phase 1, Phase 2 Interventional 18 participants sought
RayTx Clinical Site — Bakersfield, California (1.7 mi) · Sponsor: Ray Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07439887)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 109 — Bakersfield, California (1.7 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms

Benign Prostatic Hyperplasia N/A Interventional 215 participants sought
Michael G Oefelein Clinical Trials — Bakersfield, California (1.7 mi) · Sponsor: Rivermark Medical
See eligibility & contact on ClinicalTrials.gov (NCT06849258)

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Diabetic Macular Edema, DME Phase 3 Interventional 240 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: EyePoint Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07449936)

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma Phase 2 Interventional 160 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06770582)

Extension Study for the Port Delivery System With Ranibizumab (Portal)

Neovascular Age-Related Macular Degeneration Phase 3 Interventional 1,000 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT03683251)

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma Phase 3 Interventional 284 participants sought
Michael Oefelein Clinical Trials — Bakersfield, California (1.7 mi) · Sponsor: Protara Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07480356)

Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

Burnout, Burnout Syndrome N/A Interventional 203 participants sought
Bakersfield VA Clinic, VA Greater Los Angeles Healthcare System — Bakersfield, California (1.7 mi) · Sponsor: VA Greater Los Angeles Healthcare System
See eligibility & contact on ClinicalTrials.gov (NCT07031245)

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms Phase 2 Interventional 308 participants sought
Michael G Oefelein Clinical Trials ( Site 0138) — Bakersfield, California (1.7 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06833073)

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

Neovascular Age-Related Macular Degeneration (nAMD) Phase 3 Interventional 850 participants sought
California Retina Consultants (CRC) — Bakersfield, California (1.7 mi) · Sponsor: Ocular Therapeutix, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07516132)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Alopecia Areata Phase 3 Interventional 355 participants sought
Kern Research Inc. — Bakersfield, California (1.7 mi) · Sponsor: Sun Pharmaceutical Industries, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07133308)
Actively enrolling

Studies you may be able to join near Bakersfield

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Bakersfield

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Kern Research

★ 5.0
1921 18th St, Bakersfield, CA 93301
(661) 864-7710
"They have been amazing. profound results in battling my wife's alopecia. So thankful for them."
— Dennis Hilken, 5★

Trovare Clinical Research

★ 2.5
3838 San Dimas St Ste A280, Bakersfield, CA 93301
(661) 663-3096
"I went to this company seeking a solution to my medical concern,and hoping to improve the quality of my life,which has been growing worse."
— William Vines, 4★

Comprehensive Blood & Cancer Center (CBCC)

★ 4.1 (201 reviews)
6501 Truxtun Ave, Bakersfield, CA 93309
(661) 322-2206
"This place is amazing! Dr. Shambaugh is thorough and his entire staff is so efficient."
— Su R, 5★

Oncology Research Institute (ORI)

★ 5.0 (1 reviews)
9800 Brimhall Rd Ste 200, Bakersfield, CA 93312
(661) 788-5988

Happy Whole You Wellness Center

★ 4.9
2001 G St, Bakersfield, CA 93301
(661) 337-0216

Centre For Neuro Skills

★ 4.2
5215 Ashe Rd, Bakersfield, CA 93313
(661) 872-3408
"The best place on this planet to help with patient’s recovery from traumatic brain injury."
— Miguel, 5★

Labcorp

★ 3.8
3550 Q St Ste 102, Bakersfield, CA 93301
(661) 323-3353
"Oh my goodness the ladies here are so friendly and make your feel at home, and the ladies so far that have done my blood tests always, you can never …"
— BlooEyez, 5★

Clinical trials in Bakersfield: what's recruiting

The Bakersfield area currently has 65 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Bakersfield, the most active research areas are:

  • Cancer & Oncology8 studies
  • Heart & Vascular5 studies
  • Diabetes & Metabolism2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Bakersfield, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Bakersfield

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Bakersfield participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Bakersfield?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Bakersfield safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Bakersfield?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Bakersfield typically complete one or two studies per year.

Paid clinical trials near Bakersfield

Other metros within reach

Visalia, CA2 Santa Clarita, CA2,384 Lancaster, CA105 Santa Barbara, CA101 Oxnard, CA130 Thousand Oaks, CA668 Palmdale, CA129 Los Angeles, CA2,949

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Bakersfield Bladder Issues Due To Spinal Cord Injury in Bakersfield All conditions

More of CA

Long Beach3,366 Torrance3,258 Fullerton3,251 Anaheim3,193 Garden Grove3,186 Pomona3,148 Glendale2,964 Los Angeles2,949 Huntington Beach2,867 Santa Clarita2,384 Hayward2,257 Oakland2,248

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts